We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 98 → 0 (-98)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $504M → $0 (-$504M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 98

Holders
–
Holders Change
-98
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
98
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AAM
Alpine Associates Management
Florida
-$37.5M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$28.2M
3
TAL
TIG Advisors LLC
New York
-$27.1M
4
WIC
Water Island Capital
New York
-$26.3M
5
MF
Magnetar Financial
Illinois
-$23.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
BBP
26
Banco BTG Pactual
Brazil
– -$5.4M -258,105 Closed
TCM
27
Tekla Capital Management
Massachusetts
– -$5.23M -250,000 Closed
JP Morgan Chase
28
JP Morgan Chase
New York
– -$5.18M -247,830 Closed
KPF
29
K2 Principal Fund
Ontario, Canada
– -$4.36M -208,608 Closed
Invesco
30
Invesco
Georgia
– -$4.36M -208,179 Closed
HCM
31
Highbridge Capital Management
New York
– -$4.21M -201,043 Closed
OAC
32
OMERS Administration Corp
Ontario, Canada
– -$4.21M -201,000 Closed
SG Americas Securities
33
SG Americas Securities
New York
– -$4.17M -199,178 Closed
Morgan Stanley
34
Morgan Stanley
New York
– -$4.16M -199,065 Closed
GCIA
35
Gabelli & Co Investment Advisers
New York
– -$4.12M -196,992 Closed
Geode Capital Management
36
Geode Capital Management
Massachusetts
– -$3.53M -168,808 Closed
Handelsbanken Fonder
37
Handelsbanken Fonder
Sweden
– -$3.2M -153,000 Closed
HM
38
Harvest Management
New York
– -$2.93M -140,000 Closed
PCM
39
Prelude Capital Management
New York
– -$2.65M -126,701 Closed
Ameriprise
40
Ameriprise
Minnesota
– -$2.45M -117,148 Closed
HA
41
Havens Advisors
New York
– -$2.17M -103,760 Closed
TCIM
42
TIAA CREF Investment Management
New York
– -$2.16K -103,405 Closed
BIM
43
BlackRock Investment Management
Delaware
– -$2.11M -101,008 Closed
Bank of New York Mellon
44
Bank of New York Mellon
New York
– -$1.83M -87,347 Closed
Charles Schwab
45
Charles Schwab
California
– -$1.78M -85,017 Closed
CCM
46
Century Capital Management
Massachusetts
– -$1.75M -83,907 Closed
Goldman Sachs
47
Goldman Sachs
New York
– -$1.69M -80,701 Closed
TC
48
TFS Capital
Pennsylvania
– -$1.67M -80,012 Closed
SMC
49
S. Muoio & Co
New York
– -$1.67M -80,000 Closed
Credit Agricole
50
Credit Agricole
France
– -$1.64M -78,453 Closed
1
2
3 4

VTAE Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q4 2016, worth a combined $0 — down 100% from $504M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of VTAE and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Alpine Associates Management, exiting entirely with an estimated $37.5M sold.

  • 0 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q4 2016, down from 98 in Q3 2016.
  • Funds reported $0 of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q4 2016 and 98 closed out, a net change of -98 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q4 2016 was Alpine Associates Management, an estimated $37.5M sold.

Based on aggregated 13F filings for Q4 2016.